CDMO Services

Loberan pharma provides support to customer for comprehensive process development of pharma compounds and develop the most optimal process for customer compounds including New Chemical Entities (NCE), advanced intermediates, and Key Starting Materials (KSM). We keep customer's needs at the centre of our planning. We understand our customer's requirements at every stage of the journey to the clinic. To meet these varying requirements, we follow a phase-appropriate process development approach. We design our processes based on customer needs. Our interdisciplinary team designs and demonstrates our capabilities in finding sustainable synthetic routes by considering the following concepts;

Reduced cost of the molecules by choosing the most efficient route of synthesis (ROS), Reduced number of processing steps, reduced scale-up timeline, Reduced chemical or reagent norms and waste production. Avoiding expensive or difficult-to-handle raw materials, improved quality and safety profiles.

Our execution operations and SOPs are very well designed to internalize the phase-appropriate delivery. Safety, Environment, Legal, Economics, and Control and Throughput (SELECT) principles are a key component of our process development strategy.

Loberan Pharma has a material generation lab (Kilo lab) for execution the developed process at kilo scale. This facility is equipped to handle the development of small molecules, peptides, high potent compounds, steroids, carbohydrates and activated mPEGs. The same facility also provides formulation development, analytical method development & validation services. Loberan Kilo lab is equipped with a dedicated high potent lab and material generation lab with the capacities of 20L,50L,100L and 300L glass reactors for API functions.